Frances Raquel Baccus, MD | |
2401 W University Ave, Muncie, IN 47303-3428 | |
(765) 747-3111 | |
Not Available |
Full Name | Frances Raquel Baccus |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 29 Years |
Location | 2401 W University Ave, Muncie, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366431454 | NPI | - | NPPES |
010065640 | Medicaid | VA | |
AA142266 | Other | NH | HARVARD PILGRIM HEALTHCARE OF NEW ENGLAND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 01010235856 (Virginia) | Secondary |
207L00000X | Anesthesiology | 14335 (New Hampshire) | Secondary |
207L00000X | Anesthesiology | 01073575A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Goshen Hospital | Goshen, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southeast Anesthesiologists, Inc. | 6800837980 | 92 |
News Archive
Digital technologies, especially smartphone apps, have great promise for increasing access to care for patients with serious mental illness such as schizophrenia.
Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
Scientists at Institut Cochin (CNRS/Inserm/Université Paris Descartes) and ICAN - Institute of Cardiometabolism And NutritionInserm/UPMC/AP-HP) have discovered that a class of inflammatory cells, MAIT lymphocytes1, is deregulated in patients suffering from type 2 diabetes and obesity.
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.
› Verified 6 days ago
Entity Name | Beacon Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Digital technologies, especially smartphone apps, have great promise for increasing access to care for patients with serious mental illness such as schizophrenia.
Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
Scientists at Institut Cochin (CNRS/Inserm/Université Paris Descartes) and ICAN - Institute of Cardiometabolism And NutritionInserm/UPMC/AP-HP) have discovered that a class of inflammatory cells, MAIT lymphocytes1, is deregulated in patients suffering from type 2 diabetes and obesity.
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.
› Verified 6 days ago
Entity Name | Indiana University Health Ball Memorial Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
Digital technologies, especially smartphone apps, have great promise for increasing access to care for patients with serious mental illness such as schizophrenia.
Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
Scientists at Institut Cochin (CNRS/Inserm/Université Paris Descartes) and ICAN - Institute of Cardiometabolism And NutritionInserm/UPMC/AP-HP) have discovered that a class of inflammatory cells, MAIT lymphocytes1, is deregulated in patients suffering from type 2 diabetes and obesity.
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.
› Verified 6 days ago
Entity Name | Southeast Anesthesiologists, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548210685 PECOS PAC ID: 6800837980 Enrollment ID: O20050518001265 |
News Archive
Digital technologies, especially smartphone apps, have great promise for increasing access to care for patients with serious mental illness such as schizophrenia.
Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
Scientists at Institut Cochin (CNRS/Inserm/Université Paris Descartes) and ICAN - Institute of Cardiometabolism And NutritionInserm/UPMC/AP-HP) have discovered that a class of inflammatory cells, MAIT lymphocytes1, is deregulated in patients suffering from type 2 diabetes and obesity.
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Frances Raquel Baccus, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Frances Raquel Baccus, MD 2401 W University Ave, Muncie, IN 47303-3428 Ph: (765) 747-3111 |
News Archive
Digital technologies, especially smartphone apps, have great promise for increasing access to care for patients with serious mental illness such as schizophrenia.
Cytori announces the product launch of PureGraft 250, a revolutionary fat grafting technology that standardizes the graft preparation process for use in aesthetic body contouring at the American Society of Aesthetic Plastic Surgeons meeting.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
Scientists at Institut Cochin (CNRS/Inserm/Université Paris Descartes) and ICAN - Institute of Cardiometabolism And NutritionInserm/UPMC/AP-HP) have discovered that a class of inflammatory cells, MAIT lymphocytes1, is deregulated in patients suffering from type 2 diabetes and obesity.
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.
› Verified 6 days ago
Leah Bryant Jamison, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2401 W University Ave, Muncie, IN 47303 Phone: 765-751-2649 Fax: 765-281-6671 | |
Vikas Raghove, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2401 W University Ave, Muncie, IN 47303 Phone: 765-747-3111 | |
Gregory S Eskew, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2401 University Ave, Muncie, IN 47303 Phone: 765-741-3111 Fax: 765-741-1877 | |
Dr. Steve Pierre, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2401 W University Ave, Muncie, IN 47303 Phone: 765-751-2649 Fax: 765-281-6671 | |
Gregory J Allred, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2401 W University Ave, Muncie, IN 47303 Phone: 765-751-5404 Fax: 765-751-2757 | |
Dr. Michael Norman Allen, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2401 W University Ave, Muncie, IN 47303 Phone: 765-747-3111 | |
Robert M Dove, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2401 University Ave, Muncie, IN 47303 Phone: 765-741-3111 Fax: 765-741-1877 |